
Paul Yu, Ph.D., M.D.
Associate Professor of Medicine, Brigham and Women's Hospital
Publications View
Hepatopulmonary Syndrome, Another Face of Dysregulated BMP9 Signaling.
FAM222A, Part of the BET-Regulated Basal Endothelial Transcriptome, Is a Novel Determinant of Endothelial Biology and Angiogenesis-Brief Report.
Authors: Authors: Tzani A, Haemmig S, Cheng HS, Pérez-Cremades D, Heuschkel MA, Jamaiyar A, Singh SA, Aikawa M, Yu PB, Wang T, Sun Y, Feinberg MW, Plutzky J.
Arterioscler Thromb Vasc Biol
View full abstract on Pubmed
Arterioscler Thromb Vasc Biol
View full abstract on Pubmed
Novel Imaging Approaches to Cardiac Manifestations of Systemic Inflammatory Diseases: JACC Scientific Statement.
Authors: Authors: Weber BN, Paik JJ, Aghayev A, Klein AL, Mavrogeni SI, Yu PB, Mukherjee M.
J Am Coll Cardiol
View full abstract on Pubmed
J Am Coll Cardiol
View full abstract on Pubmed
Angiogenesis Redux: An Overall Protective Role of VEGF/KDR Signaling in the Microvasculature in Pulmonary Arterial Hypertension.
Cationic proteins from eosinophils bind bone morphogenetic protein receptors promoting vascular calcification and atherogenesis.
Authors: Authors: Meng Z, Zhang S, Li W, Wang Y, Wang M, Liu X, Liu CL, Liao S, Liu T, Yang C, Lindholt JS, Rasmussen LM, Obel LM, Stubbe J, Diederichsen AC, Sun Y, Chen Y, Yu PB, Libby P, Shi GP, Guo J.
Eur Heart J
View full abstract on Pubmed
Eur Heart J
View full abstract on Pubmed
Intrapulmonary arterial contraction assay reveals region-specific deregulation of vasoreactivity to lung injuries.
Authors: Authors: Bai Y, Li G, Yung L, Yu PB, Ai X.
Am J Physiol Lung Cell Mol Physiol
View full abstract on Pubmed
Am J Physiol Lung Cell Mol Physiol
View full abstract on Pubmed
Wnt7a deficit is associated with dysfunctional angiogenesis in pulmonary arterial hypertension.
Authors: Authors: Chakraborty A, Nathan A, Orcholski M, Agarwal S, Shamskhou EA, Auer N, Mitra A, Guardado ES, Swaminathan G, Condon DF, Yu J, McCarra M, Juul NH, Mallory A, Guzman-Hernandez RA, Yuan K, Rojas V, Crossno JT, Yung LM, Yu PB, Spencer T, Winn RA, Frump A, Karoor V, Lahm T, Hedlin H, Fineman JR, Lafyatis R, Knutsen CNF, Alvira CM, Cornfield DN, de Jesus Perez VA.
Eur Respir J
View full abstract on Pubmed
Eur Respir J
View full abstract on Pubmed
Diminished muscle integrity in patients with fibrodysplasia ossificans progressiva assessed with at-home electrical impedance myography.
Authors: Authors: Farid A, Golden E, Robicheau S, Hu A, Cheung K, Yu PB, Rutkove SB, Upadhyay J.
Sci Rep
View full abstract on Pubmed
Sci Rep
View full abstract on Pubmed
Decoding the Link Between Inflammation and Pulmonary Arterial Hypertension.
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1.
Authors: Authors: Aykul S, Huang L, Wang L, Das NM, Reisman S, Ray Y, Zhang Q, Rothman N, Nannuru KC, Kamat V, Brydges S, Troncone L, Johnsen L, Yu PB, Fazio S, Lees-Shepard J, Schutz K, Murphy AJ, Economides AN, Idone V, Hatsell SJ.
J Clin Invest
View full abstract on Pubmed
J Clin Invest
View full abstract on Pubmed